THE HUMAN PHARMACOLOGY OF PLATELET INHIBITION - PHARMACOKINETICS RELEVANT TO DRUG-ACTION

被引：35

作者：

PEDERSEN, AK

FITZGERALD, GA

机构：

来源：

CIRCULATION | 1985年 / 72卷 / 06期

关键词：

D O I：

10.1161/01.CIR.72.6.1164

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1164 / 1176

页数：13

共 149 条

[1]

ALI M, 1977, J LAB CLIN MED, V89, P868

[2]

ALRIDGE A, 1972, CAN J PHYSL PHARM, V50, P1061

[3]

[Anonymous], 1982, Lancet, V1, P237

[4]

[Anonymous], 1980, CIRCULATION, V62, P449

[5] MOLECULAR BASIS FOR DRUG ACTION . INTERACTION OF 1 OR MORE DRUGS WITH DIFFERENT RECEPTORS [J].

ARIENS, EJ ;

SIMONIS, AM .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1964, 16 (05) :289-&

[6] CULTURED HUMAN-SKIN FIBROBLASTS AND ARTERIAL CELLS PRODUCE A LABILE PLATELET-INHIBITORY PROSTAGLANDIN [J].

BAENZIGER, NL ;

DILLENDER, MJ ;

MAJERUS, PW .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1977, 78 (01) :294-301

[7]

BEISENHERZ G, 1960, ARZNEIMITTEL-FORSCH, V10, P307

[8]

BERTELE V, 1981, LANCET, V1, P1057

[9] MODE OF ACTION OF DIPYRIDAMOLE ON HUMAN-PLATELETS [J].

BEST, LC ;

MCGUIRE, MB ;

JONES, PBB ;

HOLLAND, TK ;

MARTIN, TJ ;

PRESTON, FE ;

SEGAL, DS ;

RUSSELL, RGG .

THROMBOSIS RESEARCH, 1979, 16 (3-4) :367-379

[10]

BJORNSSON TD, 1979, CLIN PHARMACOL THER, V26, P540

← 1 2 3 4 5 6 7 8 9 10 →